We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+22.36%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$110M
AUM Growth
+$14.7M
Cap. Flow
-$1.38M
Cap. Flow %
-1.26%
Top 10 Hldgs %
29.8%
Holding
477
New
135
Increased
70
Reduced
114
Closed
83

Sector Composition

Rank Sector Weight
1 Technology 8.58%
2 Healthcare 6.61%
3 Consumer Discretionary 5.27%
4 Financials 5.1%
5 Industrials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CZR icon
151
Caesars Entertainment
CZR
$6.13B
$161K 0.15%
+4,020
New +$111K
TDOC icon
152
Teladoc Health
TDOC
$1.29B
$161K 0.15%
845
-948
-53% -$166K
PRFZ icon
153
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.87B
$157K 0.14%
7,025
+3,225
+85% +$66.2K
RCM
154
DELISTED
R1 RCM Inc. Common Stock
RCM
$157K 0.14%
+14,125
New +$145K
UAL icon
155
United Airlines
UAL
$40.2B
$156K 0.14%
+4,520
New +$136K
WH icon
156
Wyndham Hotels & Resorts
WH
$5.29B
$154K 0.14%
+3,610
New +$147K
EXPO icon
157
Exponent
EXPO
$3.28B
$153K 0.14%
1,885
-1,400
-43% -$101K
MRVL icon
158
Marvell Technology
MRVL
$187B
$150K 0.14%
4,269
+4,180
+4,697% +$122K
DRE
159
DELISTED
Duke Realty Corp.
DRE
$150K 0.14%
4,240
-100
-2% -$3.41K
POOL icon
160
Pool Corp
POOL
$7.27B
$148K 0.14%
546
+520
+2,000% +$120K
EBS icon
161
Emergent Biosolutions
EBS
$229M
$147K 0.13%
+1,865
New +$139K
ABBV icon
162
AbbVie
ABBV
$438B
$146K 0.13%
1,485
-40
-3% -$3.52K
AKCA
163
DELISTED
Akcea Therapeutics Inc
AKCA
$146K 0.13%
+10,660
New +$164K
WST icon
164
West Pharmaceutical
WST
$24.8B
$145K 0.13%
+639
New +$126K
SFM icon
165
Sprouts Farmers Market
SFM
$7.96B
$142K 0.13%
5,552
-1,335
-19% -$30.6K
AMRX icon
166
Amneal Pharmaceuticals
AMRX
$5.71B
$141K 0.13%
+29,550
New +$122K
NPTN
167
DELISTED
NEOPHOTONICS CORP
NPTN
$141K 0.13%
+15,825
New +$136K
UCTT
168
Ultra Clean Holdings
UCTT
$3.72B
$139K 0.13%
6,155
-4,790
-44% -$91.1K
ELS icon
169
Equity Lifestyle Properties
ELS
$12.5B
$136K 0.12%
+2,170
New +$133K
OLLI icon
170
Ollie's Bargain Outlet
OLLI
$4.8B
$136K 0.12%
+1,395
New +$107K
SUI icon
171
Sun Communities
SUI
$14.4B
$135K 0.12%
+992
New +$132K
CABO icon
172
Cable One
CABO
$203M
$128K 0.12%
72
-156
-68% -$279K
EPAM icon
173
EPAM Systems
EPAM
$5.02B
$128K 0.12%
506
-104
-17% -$22.9K
POR icon
174
Portland General Electric
POR
$5.66B
$128K 0.12%
+3,060
New +$140K
SPGI icon
175
S&P Global
SPGI
$121B
$128K 0.12%
387
-99
-20% -$29.8K

Similar funds

C.M. Bidwell & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, C.M. Bidwell & Associates held 477 positions worth $110M, up 16% from $94.8M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

C.M. Bidwell & Associates's Q2 2020 filing shows 135 new, 70 increased, 114 reduced and 83 closed positions. Its largest new stake was VeriSign: 1,833 shares worth $379K. The largest sale was Vanguard S&P 500 ETF, an estimated $676K.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 7.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • C.M. Bidwell & Associates's largest Q2 2020 buy was VeriSign: 1,833 shares worth $379K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q2 2020, an estimated $1.44M increase.
  • C.M. Bidwell & Associates's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $676K.
  • C.M. Bidwell & Associates fully exited Leidos in Q2 2020, selling an estimated $598K.
  • C.M. Bidwell & Associates's ten largest holdings make up 30% of its $110M portfolio in Q2 2020.
  • C.M. Bidwell & Associates opened 135 new positions and closed 83 in Q2 2020.
  • C.M. Bidwell & Associates's portfolio value rose 16% quarter-over-quarter to $110M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2020, filed 14 Aug 2020.